C-134

Carisoprodol-¹³C₃ solution

100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant^®

• 実験式（ヒル表記法）: C₉¹³C₃H₂₄N₂O₄
• 分子量: 263.31
• EC Number: 200-659-6
• UNSPSCコード: 41116107
• NACRES: NA.24

特性

• グレード: certified reference material
• 品質水準: 300
• 形状: liquid
• 特徴: (Snap-N-Spike^®)
• 包装: ampule of 1 mL
• メーカー／製品名: Cerilliant^®
• 濃度: 100 μg/mL in methanol
• テクニック: gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• アプリケーション: clinical testing
• フォーマット: single component solution
• 保管温度: −20°C

詳細

詳細

This stable-labeled internal standard is suitable for carisoprodol testing or isotope dilution methods by LC/MS or GC/MS for applications in forensic analysis, urine drug testing, clinical toxicology, or pain prescription monitoring. Sold under trade names such as Soma and Sanoma, carisoprodol is a skeletal muscle relaxant that is often abused recreationally. Carisoprodol is purportedly used by drug users to potentiate the effects of other narcotics.

アプリケーション

• Pharmacotherapy for Spine-Related Pain in Older Adults: This study explores various pharmacotherapeutic approaches, including Carisoprodol, for managing spine-related pain in older adults, emphasizing its efficacy and safety within geriatric care (Fu JL, Perloff MD, 2022).


• Rapid Extraction and Qualitative Screening of 30 Drugs in Oral Fluid: Demonstrates the application of Carisoprodol in forensic toxicology by detailing methods for rapid drug screening in oral fluid, specifically for driving under the influence of drugs (DUID) cases (Coulter C, Garnier M, Moore C, 2022).


• Single and Multiple Dose PK-PD Characterization for Carisoprodol: Discusses a clinical trial that characterizes the pharmacokinetics and pharmacodynamics of Carisoprodol in healthy volunteers, assessing the impact of the CYP2C19 phenotype on its metabolism (Calvo A, Alonso S, Prieto E, et al., 2022).


• Tizanidine: Advances in Pharmacology & Therapeutics and Drug Formulations: Although focusing on Tizanidine, this review touches upon comparative analysis with other muscle relaxants like Carisoprodol, providing insights into therapeutic advancements and formulation strategies (Zhu LL, Wang YH, Zhou Q, 2024).

法的情報

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

安全性情報

• ピクトグラム: GHS02,GHS06,GHS08
• シグナルワード: Danger
• 危険有害性情報: H225,H301 + H311 + H331,H370
• 注意書き: P210 - P233 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311
• 危険有害性の分類: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
• ターゲットの組織: Eyes,Central nervous system
• 保管分類コード: 3 - Flammable liquids
• WGK: WGK 2
• 引火点(°F): 49.5 °F - closed cup
• 引火点(℃): 9.7 °C - closed cup